% | $
Quotes you view appear here for quick access.

Catalyst Pharmaceuticals, Inc. Message Board

  • warrenreport warrenreport Jul 28, 2013 2:17 PM Flag

    Best to buy now while CPRX is cheap

    Shares will be much higher in comings weeks and months as the company gets ready to start the phase III trial for Firdapse. Firdapse should pass easily because it is already approved and selling in Europe.

    The big unknown is the price that BioMarin is going to pay for the balance of CPRX stock so they can own CPP115. CPP115 will be a mega blockbuster.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.794-0.086(-9.77%)Jun 24 4:00 PMEDT